| Related Information: |
| European Union: Nitrosamines: EMA aligns recommendations for sartans with those ... 上载于 2020-11-14 |
| The United States: FDA updates and press announcements on angiotensin II recepto... 上载于 2019-11-14 |
| The United States: Torrent Pharmaceuticals Limited expands voluntary nationwide ... 上载于 2019-09-21 |
| United States: Macleods Pharmaceutical Limited Issues Voluntary Nationwide Consu... 上载于 2019-06-27 |
| The United States: Teva Pharmaceuticals USA, Inc. expands voluntary nationwide r... 上载于 2019-06-12 |
| The United States: Sciegen Pharmaceuticals, Inc. issues voluntary nationwide rec... 上载于 2019-06-12 |
| Singapore: Recall of three brands of losartan products found to contain N-Nitros... 上载于 2019-05-09 |
| The United States: Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Rec... 上载于 2019-05-04 |
| The United States: Teva Pharmaceuticals USA, Inc. issues voluntary nationwide re... 上载于 2019-04-29 |
| The United States: Legacy Pharmaceutical Packaging, LLC expands voluntary nation... 上载于 2019-04-25 |
| Canada: Auro Pharma Inc. voluntarily recalls one lot of Auro-Irbesartan HCT tabl... 上载于 2019-04-23 |
| The United States: Updated: Torrent Pharmaceuticals Limited expands voluntary na... 上载于 2019-04-23 |
| Singapore: HSA recalls three brands of losartan medicines from Hetero Labs Ltd (... 上载于 2019-03-29 |
| 台湾：回收缓压膜衣锭 50 毫克 Losacar 50 Tablets 上载于 2019-03-23 |
| 台湾：回收压宁悦膜衣锭 50/12.5 毫克 Hysartan F.C. Tablets 50/12.5 mg 上载于 2019-03-23 |
| The United Kingdom: Class 2 Medicines recall: Accord Healthcare Limited - Losart... 上载于 2019-03-22 |
| The United States: Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationw... 上载于 2019-03-16 |
| Canada: Pro Doc Limitée voluntarily recalls two lots of irbesartan drugs because... 上载于 2019-03-15 |
| Canada: Multiple losartan-containing drugs voluntarily recalled because of poten... 上载于 2019-03-11 |
| The United States: American Health Packaging issues voluntary nationwide recall ... 上载于 2019-03-08 |
| 台湾：Sartan类高血压又发现新的不纯物NMBA，食药署启动预防性下架机制 上载于 2019-03-04 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... 上载于 2019-03-02 |
| The United States: Aurobindo Pharma USA, Inc. initiates a voluntary nationwide c... 上载于 2019-03-02 |
| The United States: Camber Pharmaceuticals, Inc. issues voluntary nationwide reca... 上载于 2019-03-01 |
| 台湾：食药署说明沙坦类（sartan）药品中「N-亚硝基二甲胺（NDMA）」及「N-亚硝基二乙胺（NDEA）」之处理现况 上载于 2019-02-28 |
| The United States: Macleods Pharmaceuticals Limited issues voluntary nationwide ... 上载于 2019-02-26 |
| Australia: ‘Sartan’ blood pressure medicines: TGA investigation - potential cont... 上载于 2019-02-26 |
| 台湾：有关健乔信元医药生技股份有限公司「卫欣保膜衣锭80毫克」、「卫欣保膜衣锭160毫克」及景德制药股份有限公司「"景德"定压宁胶囊80毫克」回收事件说明 上载于 2019-02-16 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - Irbesartan... 上载于 2019-02-14 |
| European Medicines Agency: Press release: Sartan medicines: companies to review ... 上载于 2019-02-02 |
| The United Kingdom: Class 2 Medicines Recall: Macleods Pharma UK Limited - Irbes... 上载于 2019-01-25 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... 上载于 2019-01-23 |
| 台湾：食药署说明目前完成清查沙坦类（Sartan）药品中「N-亚硝基二甲胺（NDMA）」及「N-亚硝基二乙胺（NDEA）」之检验结果 上载于 2019-01-21 |
| The United States: Prinston Pharmaceutical Inc. issues voluntary nationwide reca... 上载于 2019-01-19 |
| The United Kingdom: Class 2 Medicines Recall: Actavis Group PTC EHF - recall of ... 上载于 2019-01-04 |
| The United States: Aurobindo Pharma USA, Inc. initiates voluntary nationwide con... 上载于 2019-01-02 |
| 台湾: 有关寿元化学工业股份有限公司回收「脉莎平膜衣锭 50 毫克」事件说明 上载于 2018-12-31 |
| 台湾: 回收脉莎平膜衣锭 50 毫克 Cosar F.C. Tablets 50 mg 上载于 2018-12-28 |
| Canada: Health Canada releases test results of certain sartan drugs (English Onl... 上载于 2018-12-21 |
| The United States: Torrent Pharmaceuticals Limited issues voluntary nationwide r... 上载于 2018-12-21 |
| Australia: Recall for IRBESARTAN／HCT SANDOZ 300／12.5 and IRBESARTAN／HCT SANDOZ 3... 上载于 2018-12-19 |
| Australia: Recall - potential contamination: APO-Valsartan (valsartan) tablets (... 上载于 2018-12-19 |
| The United States: FDA warns API manufacturer involved in valsartan recall, prov... 上载于 2018-12-12 |
| The United States: Mylan expands its voluntary nationwide recall of Valsartan Ta... 上载于 2018-12-05 |
| The United Kingdom: Class 2 Medicines Recall: Teva UK Limited and Mylan - recall... 上载于 2018-12-01 |
| Canada: Information Update - Mylan-Valsartan medications voluntarily recalled as... 上载于 2018-11-30 |
| The United States: Teva Pharmaceuticals USA issues voluntary nationwide recall o... 上载于 2018-11-28 |
| Australia: Recall - potential contamination: Dilart and Dilart HCT (valsartan) (... 上载于 2018-11-23 |
| 台湾：回收洛沙坦山德士膜衣锭50/12.5毫克 Losartan Sandoz Comp Film Coated Tablet 50/12.5 mg 上载于 2018-11-23 |
| The United States: Mylan initiates voluntary nationwide recall of 15 lots of Val... 上载于 2018-11-22 |
| 台湾：有关健亚生物科技股份有限公司回收「压稳膜衣锭80毫克」及「压稳膜衣锭160毫克」事件说明 上载于 2018-11-21 |
| 台湾：回收压稳膜衣锭80毫克 Prevan Film-Coated Tablets 80mg 上载于 2018-11-20 |
| European Union: Valsartan from Mylan laboratories in India can no longer be used... 上载于 2018-11-20 |
| 台湾：回收压稳膜衣锭160毫克 Prevan Film-coated Tablets 160mg 上载于 2018-11-20 |
| The United States: Sandoz Inc. issues voluntary nationwide recall of one lot of ... 上载于 2018-11-10 |
| 台湾：食药署调查使用印度Aurobindo Pharma Limited公司Irbesartan原料药之异常事件说明，及回收「平压妥膜衣锭300毫克Bestan... 上载于 2018-11-03 |
| The United States: ScieGen Pharmaceuticals, Inc. issues voluntary nationwide rec... 上载于 2018-10-31 |
| The United States: Aurobindo Pharma Limited issues voluntary recall of irbesarta... 上载于 2018-10-30 |
| The United States: FDA updates recalled valsartan-containing product information... 上载于 2018-10-25 |
| European Union: EU authorities take further action in ongoing review of sartans:... 上载于 2018-10-16 |
| The United States: FDA posts laboratory analysis of NDMA levels in recalled vals... 上载于 2018-10-06 |
| Canada: Health Canada finds Zhejiang Huahai Pharmaceuticals site non-compliant w... 上载于 2018-10-03 |
| The United States: FDA places Zhejiang Huahai Pharmaceuticals on import alert (E... 上载于 2018-10-02 |
| European Union: EU inspection finds Zhejiang Huahai site non-compliant for manuf... 上载于 2018-09-29 |
| European Union: Valsartan: review of impurities extended to other sartan medicin... 上载于 2018-09-22 |
| European Union: Update on review of valsartan medicines. Risk from NDMA remains ... 上载于 2018-09-14 |
| The United States: FDA provides update on its ongoing investigation into valsart... 上载于 2018-09-14 |
| Canada: Health Canada advises of a second impurity linked to recalled valsartan ... 上载于 2018-09-14 |
| Canada: Health Canada updates Canadians on estimates of health risks for recalle... 上载于 2018-09-11 |
| The United States: Updated: Torrent Pharmaceuticals Limited issues voluntary nat... 上载于 2018-09-01 |
| 美国：更新：Torrent Pharmaceuticals Limited自愿全国性回收Valsartan/Amlodipine/HCTZ Tablets、Va... 上载于 2018-08-22 |
| 欧洲联盟：有关含有浙江天宇缬沙坦药物的资料更新。因含有NDMA该公司不再获授权生产用于欧洲联盟药品的缬沙坦原料药 上载于 2018-08-21 |
| 加拿大：Teva Canada扩大回收额外批次的缬沙坦药物以作为预防措施 上载于 2018-08-20 |
| 美国：Torrent Pharmaceuticals Limited自愿全国性回收Valsartan/Amlodipine/HCTZ Tablets 上载于 2018-08-20 |
| 欧洲联盟：审查缬沙坦药物检测到NDMA的更新。欧洲药物监管局正审查另一家公司(浙江天宇)生产的缬沙坦。 上载于 2018-08-11 |
| 美国：Camber Pharmaceuticals, Inc.因在原料药中检测到微量N-nitrosodimethylamine (NDMA)杂质自愿全国性回收... 上载于 2018-08-10 |
| 美国：食物及药物管理局有关回收缬沙坦药物的更新 上载于 2018-08-08 |
| 欧洲联盟：回收缬沙坦药物的审查更新。初步评估可能给病人带来的风险。 上载于 2018-08-03 |
| 台湾：食药署全面调查valsartan原料药异常事件说明 上载于 2018-08-03 |
| Updates on the recall of valsartan-containing products (Letter to Healthcare Pro... 上载于 2018-08-03 |
| 美国：食物及药物管理局更新给医护专业人员和病人有关缬沙坦药物回收的信息 上载于 2018-07-19 |
| 欧洲联盟：在原料药检测到杂质后审查缬沙坦药物的更新 上载于 2018-07-18 |
| 美国：食物及药物管理局在检测到杂质后宣布自愿回收几种含有缬沙坦的药物 上载于 2018-07-14 |
| 英国：第一级药物回收：立即采取行动 - 包括非办公时间药房回收(含有缬沙坦的药物) 上载于 2018-07-11 |
| 台湾：食药署调查使用中国大陆浙江华海制药公司valsartan原料药之异常事件接续说明 上载于 2018-07-10 |
| 加拿大：因受潜在致癌物污染而回收几种含有缬沙坦的药物 上载于 2018-07-10 |
| Recall of five valsartan-containing products (Letter to Healthcare Professionals... 上载于 2018-07-09 |
| 澳门：回收六款药物 上载于 2018-07-09 |
| 欧洲联盟：欧洲药物监管局在检测到杂质后审查含有Zhejiang Huahai缬沙坦的药物。一些缬沙坦药物在欧洲联盟市场上回收。 上载于 2018-07-06 |
| 英国：从药房回收血压和心脏科药物(缬沙坦) 上载于 2018-07-06 |
| Recall of five valsartan-containing products (Letter to Healthcare Professionals... 上载于 2018-07-06 |
